comparemela.com

Latest Breaking News On - Katsuhiko murakami - Page 2 : comparemela.com

COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs

COVID-19 antiviral drug candidates that inhibit SARS-CoV-2 proteases have been identified with novel screening strategy.

Repurposing FDA-approved drugs may help combat COVID-19

Repurposing FDA-approved drugs may help combat Covid

Several FDA-approved drugs including for type 2 diabetes, hepatitis C and HIV significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, finds new research.Specifically, the team found that these .

Repurposing FDA-approved drugs may help combat Covid

Repurposing FDA-approved drugs may help combat Covid
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Solving ancient problem of nucleic acid synthesis helps to design new antiviral drugs

 E-Mail An international team of scientists from the University of Turku, Finland and PennState University, USA have solved a long-standing mystery of how living organisms distinguish RNA and DNA building blocks during gene expression paving the way for the design of new antiviral drugs. The new insights were published in the journal Nature Communications. All cellular organisms use two types of nucleic acids, RNA and DNA to store, propagate and utilize their genetic information. The synthesis of DNA is carried out by enzymes called DNA polymerases and is needed to accurately transfer the genetic information from generation to generation. Synthesis of RNA is carried out by enzymes called RNA polymerases and is needed to utilize the genetic information to ultimately produce proteins that in turn fulfil most structural and catalytic functions in all modern-day living organisms.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.